-
STAT+: Contineum Therapeutics files for IPO
18 Mar 2024 14:52 GMT
… labs, see a new biopharma IPO in the works, and expect … need-to-know this morning
Bluebird Bio, in the early stages of …
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm
22 Apr 2024 01:00 GMT
… Group, Inc. (NASDAQ: SHLS), and Bluebird bio Inc. (NASDAQ: BLUE). Stockholders have … the April 2021 initial public offering of Agilon stock (the “IPO”); (2) pursuant, or … .com/cases/SHLS Bluebird bio Inc. (NASDAQ: BLUE) Class Period …
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm
18 Apr 2024 01:00 GMT
… Group, Inc. (NASDAQ: SHLS), and Bluebird bio Inc. (NASDAQ: BLUE). Stockholders have … the April 2021 initial public offering of Agilon stock (the “IPO”); (2) pursuant, or … .com/cases/SHLS Bluebird bio Inc. (NASDAQ: BLUE) Class Period …
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm
14 Apr 2024 01:00 GMT
… Group, Inc. (NASDAQ: SHLS), and Bluebird bio Inc. (NASDAQ: BLUE). Stockholders have … the April 2021 initial public offering of Agilon stock (the “IPO”); (2) pursuant, or … .com/cases/SHLS Bluebird bio Inc. (NASDAQ: BLUE) Class Period …
-
bluebird bio Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer
03 Jan 2023 13:58 GMT
… Vittiglio guided the company’s initial public offering in 2021, which raised $ … product launches.
About bluebird bio, Inc.
bluebird bio is pursuing curative gene … and YouTube.
bluebird bio is a trademark of bluebird bio, Inc.
bluebird bio Cautionary Statement …
-
Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket
19 Sep 2022 13:15 GMT
… after declining 17% on Friday.
bluebird bio, Inc. BLUE rose 18. … 52 in pre-market trading. bluebird bio disclosed that the Food and … Friday. Nexalin Technology priced its IPO at $4.15 per … pre-market trading amid post-IPO volatility.
Marathon Digital Holdings, …
-
bluebird bio: Potential For 3 Gene Therapy Approvals In 12 Months Makes Buy Case
22 Jun 2022 18:43 GMT
… more than a decade, bluebird bio has helped chart the path … in a press release announcing bluebird bio's (NASDAQ:BLUE) … Beam Therapeutics (BEAM) has IPO'd, showcasing a potentially … bluebird Stock Looks Tempting bluebird bio has experienced more than …
-
Stock Down 98% From Peak, Bluebird Bio Could Run Out Of Cash
22 Apr 2022 18:15 GMT
… layoffs, Bluebird Bio’s cash position is weak
Bluebird Bio’s … March, Akebia Therapeutics, Bluebird Bio, and Yumanity Therapeutics … Globe.
Bluebird Bio’s Weak Cash Position
Bluebird Bio’s stock … name to bluebird bio, according to its IPO prospectus.
In …
-
bluebird Seeks Funding Through 2024 with IPO
20 Jan 2023 01:26 GMT
… /LightRocket via Getty Images
bluebird bio is expecting gross proceeds of … benefit from the company’s IPO. bluebird reported preliminary unaudited cash …
-
Just after ASCO, China's Legend Biotech raises nearly $424M in initial public offering
08 Jun 2020 19:54 GMT
… $423.8 million in its initial public offering on the Nasdaq, under the … aimed for a $100 million IPO last month. Shares of the … a partnership between BMS and bluebird bio.
Photo: Spencer Platt, Getty Images